These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. New chemotherapeutic agents in non-small-cell lung cancer. Feigal EG; Christian M; Cheson B; Grever M; Friedman MA Semin Oncol; 1993 Apr; 20(2):185-201. PubMed ID: 7683142 [No Abstract] [Full Text] [Related]
23. [Vinorelbine in the treatment of non-small-cell lung cancer and breast cancer]. Kubota K Gan To Kagaku Ryoho; 2000 Jul; 27(8):1301-6. PubMed ID: 10945030 [TBL] [Abstract][Full Text] [Related]
24. Treatment of non-small-cell lung cancer in North America: the emerging role of irinotecan. Langer CJ Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):19-24. PubMed ID: 11221017 [TBL] [Abstract][Full Text] [Related]
25. Single-agent vinorelbine in the treatment of non-small cell lung cancer. Wozniak AJ Semin Oncol; 1999 Oct; 26(5 Suppl 16):62-6; discussion 71-2. PubMed ID: 10585010 [TBL] [Abstract][Full Text] [Related]
26. The role of granulocyte growth factors in the treatment of non small cell lung cancer. Gridelli C; Barzelloni ML; Barletta E; Guida C; Gatani T; Fiore F; Scognamiglio F Clin Ter; 1999; 150(3):231-4. PubMed ID: 10528437 [TBL] [Abstract][Full Text] [Related]
27. Docetaxel in the management of advanced non-small cell lung cancer. Miller VA Semin Oncol; 1998 Jun; 25(3 Suppl 8):15-9. PubMed ID: 9704671 [TBL] [Abstract][Full Text] [Related]
28. Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer. Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Papadakis E; Bouros D; Apostolopoulou F; Georgopoulou T; Agelidou M; Souglakos J; Halkiadakis G; Hatzidaki D Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-9-S14-14. PubMed ID: 9335517 [TBL] [Abstract][Full Text] [Related]
29. Irinotecan in small-cell lung cancer: the US experience. Sandler AB Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):11-2. PubMed ID: 11221015 [TBL] [Abstract][Full Text] [Related]
30. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network. Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330 [TBL] [Abstract][Full Text] [Related]
31. Is cisplatin required for the treatment of non-small-cell lung cancer? Experience and preliminary results of a phase I/II trial with topotecan and vinorelbine. Stupp R; Bodmer A; Duvoisin B; Bauer J; Perey L; Bakr M; Ketterer N; Leyvraz S Oncology; 2001; 61 Suppl 1():35-41. PubMed ID: 11598413 [TBL] [Abstract][Full Text] [Related]
32. [Recent results of anticancer drugs acting on microtubules--navelbine, taxol and taxotere for the treatment of lung cancer]. Kawahara M; Furuse K Gan To Kagaku Ryoho; 1992 Nov; 19(13):2150-6. PubMed ID: 1359840 [No Abstract] [Full Text] [Related]
33. New options for the treatment of advanced ovarian cancer. Dunton CJ Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739 [TBL] [Abstract][Full Text] [Related]
34. New options in the treatment of non-small cell lung cancer. Fossella F; Rigas JR; Belani CP Anticancer Drugs; 1999 Nov; 10 Suppl 1():S25-8. PubMed ID: 10630365 [TBL] [Abstract][Full Text] [Related]
39. Vinorelbine for non-small cell lung cancer. Piccirillo MC; Daniele G; Di Maio M; Bryce J; De Feo G; Del Giudice A; Perrone F; Morabito A Expert Opin Drug Saf; 2010 May; 9(3):493-510. PubMed ID: 20350282 [TBL] [Abstract][Full Text] [Related]